Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
China · Delayed Price · Currency is CNY 10.18
-0.22 (-2.12%)
May 20, 2026, 11:54 AM CST
SHE:002399 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 380.47 | 349.49 | 646.74 | -783.26 | 727.43 | 240.79 |
Depreciation & Amortization | 354.57 | 354.57 | 331.05 | 361.23 | 307.66 | 302.74 |
Other Amortization | 28.87 | 28.87 | 10.22 | 16.61 | 10.54 | 4.64 |
Loss (Gain) From Sale of Assets | -1.84 | -1.84 | -0.72 | 1.68 | 2.76 | 5.1 |
Asset Writedown & Restructuring Costs | 105.07 | 105.07 | -75.62 | 112.67 | 0.42 | 1.1 |
Loss (Gain) From Sale of Investments | 116.13 | 116.13 | -110.42 | 6.35 | 175.2 | 226.82 |
Loss (Gain) on Equity Investments | - | - | - | 447.95 | - | - |
Provision & Write-off of Bad Debts | 17.98 | 17.98 | 28.55 | - | 48.86 | 71.85 |
Other Operating Activities | -37.64 | 160.63 | 160.98 | -126.46 | 283.59 | 267.7 |
Change in Accounts Receivable | -132.51 | -132.51 | -25.38 | 316.89 | -176.1 | 141.77 |
Change in Inventory | 914.21 | 914.21 | 1,245 | 189.8 | -2,152 | -1,520 |
Change in Accounts Payable | -143.67 | -143.67 | -63.43 | -125.21 | 59.71 | 423.9 |
Change in Unearned Revenue | - | - | - | -68.29 | - | - |
Change in Other Net Operating Assets | - | - | - | 48.25 | -1.46 | -2.24 |
Operating Cash Flow | 1,546 | 1,713 | 2,194 | 398.22 | -756.61 | -6.63 |
Operating Cash Flow Growth | -16.80% | -21.93% | 450.99% | - | - | - |
Capital Expenditures | -101.23 | -121.1 | -202.77 | -437.43 | -222.42 | -193.86 |
Sale of Property, Plant & Equipment | 0.9 | 2.17 | 3.01 | 2.34 | 2.53 | 1.72 |
Divestitures | 30.6 | 9.9 | - | - | - | - |
Sale (Purchase) of Intangibles | - | - | - | -7.45 | - | - |
Investment in Securities | -792.37 | -824.92 | -545.21 | 1,565 | 336.53 | 323.36 |
Other Investing Activities | 41.5 | 61.2 | 329.91 | 99.36 | 133.2 | 588.71 |
Investing Cash Flow | -820.6 | -872.75 | -415.05 | 1,222 | 249.84 | 719.93 |
Long-Term Debt Issued | - | 2,428 | 2,687 | 5,109 | 6,756 | 3,694 |
Long-Term Debt Repaid | - | -3,092 | -4,691 | -6,033 | -6,162 | -3,767 |
Net Debt Issued (Repaid) | -423.84 | -663.76 | -2,005 | -923.29 | 594.15 | -72.79 |
Common Dividends Paid | -421.53 | -430.81 | -159.9 | -176.21 | -251.01 | -412.48 |
Other Financing Activities | -2.11 | - | 24.81 | -110.68 | -13.58 | -15.81 |
Financing Cash Flow | -847.47 | -1,095 | -2,140 | -1,210 | 329.56 | -501.08 |
Foreign Exchange Rate Adjustments | -7.07 | 21.04 | 16.83 | 36.33 | 17.28 | -62.83 |
Net Cash Flow | -129.47 | -233.32 | -343.82 | 445.94 | -159.93 | 149.39 |
Free Cash Flow | 1,444 | 1,592 | 1,991 | -39.22 | -979.03 | -200.49 |
Free Cash Flow Growth | -13.73% | -20.06% | - | - | - | - |
Free Cash Flow Margin | 26.67% | 29.05% | 37.71% | -0.72% | -13.68% | -3.15% |
Free Cash Flow Per Share | 0.98 | 1.08 | 1.36 | -0.03 | -0.67 | -0.14 |
Cash Interest Paid | - | - | - | 249.83 | - | - |
Cash Income Tax Paid | 306.44 | 145.99 | 247.73 | 62.14 | -270.8 | -129.34 |
Levered Free Cash Flow | 1,275 | 1,340 | 1,632 | 183.13 | -1,494 | -435.43 |
Unlevered Free Cash Flow | 1,319 | 1,385 | 1,720 | 322.64 | -1,347 | -309.41 |
Change in Working Capital | 582.06 | 582.06 | 1,203 | 361.44 | -2,313 | -1,127 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.